This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cramer's 'Mad Money' Recap: A Murphy's Law Market

Papa shed some light on his company's recent acquisition of the Irish-based Elan, saying the merger gives Perrigo three things: a start towards global growth, solid licensing revenue and, as has been widely reported, having operations based in Ireland rather than the U.S. affords Perrigo over $150 million in annual tax savings.

Turning to the company's current business, Papa said three trends continue to drive double-digit growth for Perrigo. The first is the trend of prescription drugs going over the counter, the second is the move from national to private label brands and the third is Perrigo's innovation, where the company plans to introduce 75 new products this year, representing $190 million in potential sales.

Cramer called Perrigo a great growth story and one he plans on continuing to follow.

Off the Charts

In the "Off The Charts" segment, Cramer turned to colleague Carly Garner to analyze the next moves in natural gas. Is this year's seasonal low the time to buy, buy, buy? According to Garner, yes!

Looking at a daily chart of natural gas futures, Garner noted there's a huge short position being held by large speculators betting that the commodity will sink even lower. However, both the relative strength and William's oscillator, two measures of momentum, point to a huge oversold condition that's ready to snap in the other direction.

Garner further noted that, seasonally, this is the best time to buy natural gas as utilities begin stocking up for the cold winter season. It's also worth noting that nat gas held its key level of $3.20 last week, a move that prompted Garner to call that the bottom has indeed been made.

How high can gas rally? Garner said there's a ceiling at $3.47, which should easily breached, sending the commodity to the $3.80 or possibly the $4.40 level. Ultimately, Garner even sees natural gas possibly retesting its July highs of $5.20.

Cramer said that he's on board with Garner, saying that while the speculators are betting on further weakness, the lower prices continue to force drillers to stop drilling, which will eventually call cause the commodity to snap back in a big way. He said if Garner says that time is now, that's good enough for him.

Lightning Round

In the Lightning Round, Cramer was bullish on Hanesbrands (HBI), Domino's Pizza (DPZ), General Mills (GIS), Sonic (SONC), Bloomin' Brands (BLMN), Red Robin Gourmet Burgers (RRGB) and Occidental Petroleum (OXY).

Cramer was bearish on Simon Property Group (SPG), Callaway Golf (ELY), JA Solar (JASO) and Abercrombie & Fitch (ANF).

Off the Charts, Part 2

For his second "Off The Charts" segment, Cramer turned to colleague and chartist Mark Sebastian to examine the CBOE Volatility Index (VIX), more commonly known by its ticker, the VIX, to determine just how much fear is building in the markets.

According to traditional logic, any time the markets are rising the VIX should be falling, and vice versa. So closely linked is this inverse relationship that, according to Sebastian, any time the market moves and the VIX doesn't follow, that's the time to jump in.

Such was the case in June of this year. The S&P 500 had been falling sharply, and the VIX, as it should, was exploding. But then on June 24, the correlation broke down and the S&P tanked but the VIX didn't make a fresh high. That move signaled the bottom and an excellent time to buy.

Flash forward to today when we see the same pattern. The markets have been falling and the VIX has been on the rise, until the latter part of today when the S&P retested its lows but the VIX held firm. According to Sebastian, that signals the markets are done with their selling, at least for now.

Mad Mail

In the "Mad Mail" viewer feedback segment, Cramer followed up on OncoMed (OMED), which stumped him on an earlier show. He said that after liking the IPO, he advised selling the tiny biotech. Now, however, Cramer said he likes the company's pipeline as long as shares can hold above their IPO price of $17 a share.

Cramer was bearish on Natural Grocers (NGVC), a healthy eating stock that's richly valued at 70 times earnings. He was also not a fan of Immunomedics (IMMU) or Avanir Pharmaceuticals (AVNR), which are up 75% and 85%, respectively, so far this year.

Cramer was bullish, however, on Lululemon Athletica (LULU), Radian Group (RDN) and Walt Disney (DIS) as he responded to tweets sent via Twitter to @JimCramer.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

-- Written by Scott Rutt in Washington, D.C.

To email Scott about this article, click here: Scott Rutt

Follow Scott on Twitter @ScottRutt or get updates on Facebook, ScottRuttDC
At the time of publication, Cramer's Action Alerts PLUS had a position in CSCO.

Jim Cramer, host of the CNBC television program "Mad Money," is a Markets Commentator for, Inc., and CNBC, and a director and co-founder of All opinions expressed by Mr. Cramer on "Mad Money" are his own and do not reflect the opinions of or its affiliates, or CNBC, NBC Universal or their parent company or affiliates. Mr. Cramer's opinions are based upon information he considers to be reliable, but neither, nor CNBC, nor either of their affiliates and/or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. Mr. Cramer's statements are based on his opinions at the time statements are made, and are subject to change without notice. No part of Mr. Cramer's compensation from CNBC or is related to the specific opinions expressed by him on "Mad Money."

None of the information contained in "Mad Money" constitutes a recommendation by Mr. Cramer, or CNBC that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the program. Mr. Cramer's past results are not necessarily indicative of future performance. Neither Mr. Cramer, nor, nor CNBC guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the program. The strategy or investments discussed may fluctuate in price or value and you may get back less than you invested. Before acting on any information contained in the program, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Some of the stocks mentioned by Mr. Cramer on "Mad Money" are held in Mr. Cramer's Action Alerts PLUS Portfolio. When that is the case, appropriate disclosure is made on the program and in the "Mad Money" recap available on The Action Alerts PLUS Portfolio contains all of Mr. Cramer's personal investments in publicly-traded equity securities only, and does not include any mutual fund holdings or other institutionally managed assets, private equity investments, or his holdings in, Inc. Since March 2005, the Action Alerts PLUS Portfolio has been held by a Trust, the realized profits from which have been pledged to charity. Mr. Cramer retains full investment discretion with respect to all securities contained in the Trust. Mr. Cramer is subject to certain trading restrictions, and must hold all securities in the Action Alerts PLUS Portfolio for at least one month, and is not permitted to buy or sell any security he has spoken about on television or on his radio program for five days following the broadcast.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
PRGO $137.41 -4.50%
AAPL $95.01 1.05%
FB $97.40 -6.40%
GOOG $682.74 -0.12%
TSLA $142.31 -12.00%


Chart of I:DJI
DOW 16,027.05 -177.92 -1.10%
S&P 500 1,853.44 -26.61 -1.42%
NASDAQ 4,283.7530 -79.3910 -1.82%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs